Polygiene (POLYG) Q3 2024 earnings summary

Executive summary

• Achieved strong quarterly growth and profitability, with positive cash flow and improved investor relations.

• Net sales for Q3 2024 reached SEK 40.8 million, up 42% year-over-year, with a gross margin of 71.6% and EBITDA of SEK 5.7 million, including SEK 1.3 million in extraordinary costs.

• Accumulated sales through September matched the previous year's total, reflecting sustained momentum.

• Strategic collaborations, new product launches, and innovation partners contributed to growth, especially in EMEA and APAC.

Financial highlights

• Sales reached SEK 40.8 million, up 42% year-over-year, with a -3.4% FX impact.

• Gross margin was 71.6% compared to 72.2% last year.

• EBITDA improved to SEK 5.7 million from -SEK 1 million, including SEK 1.3 million in extraordinary costs; EBIT at SEK 4.2 million from -SEK 2.4 million.

• Positive cash flow of SEK 3.8 million, with SEK 58.2 million in cash at period end.

• Operating costs increased by SEK 1.2 million, including SEK 1.3 million in extraordinary costs.

Outlook and guidance

• Focus remains on growth strategies: organic growth, product development, new markets, and M&A.

• Management expects continued profitability and growth, leveraging a scalable business model and strong liquidity.

• The company aims to finish the year on a positive note, with a focus on long-term shareholder value.

• Market recovery is evident, with brands resuming investments and expanding collections.

• Ongoing action plans to drive top-line growth and leverage scalable business model.